Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial
Background and aims The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces...
Saved in:
| Published in | European heart journal. Quality of care & clinical outcomes Vol. 10; no. 5; pp. 411 - 420 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Oxford University Press
01.08.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2058-5225 2058-1742 2058-1742 |
| DOI | 10.1093/ehjqcco/qcae004 |
Cover
| Abstract | Background and aims
The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial.
Methods
Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference.
Results
Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI −1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies.
Conclusions
Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies.
Graphical Abstract
Graphical Abstract
Overview of the study design and outcomes. |
|---|---|
| AbstractList | The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial.BACKGROUND AND AIMSThe healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial.Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference.METHODSLow-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference.Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI -1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies.RESULTSFollow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI -1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies.Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies.CONCLUSIONSPre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. Graphical Abstract Overview of the study design and outcomes. Background and aims The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial. Methods Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference. Results Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy ([euro]1932 [+ or -] [euro]2784 vs. [euro]2649 [+ or -] [euro]2750), mean difference [euro]717 [95% confidence interval (CI) [euro]347 to [euro]1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI -1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies. Conclusions Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. Graphical Overview of the study design and outcomes. Keywords Acute coronary syndrome * Point-of-care troponin * Ambulance * Healthcare economics * Cost-effectiveness The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial. Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference. Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy ([euro]1932 [+ or -] [euro]2784 vs. [euro]2649 [+ or -] [euro]2750), mean difference [euro]717 [95% confidence interval (CI) [euro]347 to [euro]1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI -1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies. Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. Background and aims The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial. Methods Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference. Results Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI −1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies. Conclusions Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial. Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference. Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI -1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies. Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. Background and aims The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial. Methods Low-risk patients with suspected NSTE-ACS were randomized to pre-hospital rule-out with POC troponin measurement or emergency department (ED) transfer. Primary 1-year outcome was healthcare costs. Secondary outcomes were safety, quality of life (QoL), and cost-effectiveness. Safety was defined as a 1-year MACE consisting of ACS, unplanned revascularization, or all-cause death. QoL was measured with EuroQol-5D-5L questionnaires. Cost-effectiveness was defined as 1-year healthcare costs difference per QoL difference. Results Follow-up was completed for all 863 patients. Healthcare costs were significantly lower in the pre-hospital strategy (€1932 ± €2784 vs. €2649 ± €2750), mean difference €717 [95% confidence interval (CI) €347 to €1087; P < 0.001]. In the total population, the 1-year MACE rate was comparable between groups [5.1% (22/434) in the pre-hospital strategy vs. 4.2% (18/429) in the ED strategy; P = 0.54]. In the ruled-out ACS population, 1-year MACE remained low [1.7% (7/419) vs. 1.4% (6/417)], risk difference 0.2% (95% CI −1.4% to 1.9%; P = 0.79). QoL showed no significant difference between strategies. Conclusions Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies. Graphical Abstract Graphical Abstract Overview of the study design and outcomes. |
| Audience | Academic |
| Author | van Kimmenade, Roland R J Zegers, Erwin Rutten, Martijn H Cramer, Gilbert E Aarts, Goaris W A Rodwell, Laura de Wit, Walter van Royen, Niels van Hout, Roger Hoare, Anouk van Geuns, Robert-Jan M Ouwendijk, Eva Gomes, Marc E R Brok, Gijs Damman, Peter Adang, Eddy M M Camaro, Cyril de Pooter, Frank |
| Author_xml | – sequence: 1 givenname: Goaris W A orcidid: 0000-0003-4912-295X surname: Aarts fullname: Aarts, Goaris W A – sequence: 2 givenname: Cyril orcidid: 0000-0001-6170-8318 surname: Camaro fullname: Camaro, Cyril – sequence: 3 givenname: Eddy M M orcidid: 0000-0002-4773-6176 surname: Adang fullname: Adang, Eddy M M – sequence: 4 givenname: Laura orcidid: 0000-0003-2706-9326 surname: Rodwell fullname: Rodwell, Laura – sequence: 5 givenname: Roger surname: van Hout fullname: van Hout, Roger – sequence: 6 givenname: Gijs surname: Brok fullname: Brok, Gijs – sequence: 7 givenname: Anouk surname: Hoare fullname: Hoare, Anouk – sequence: 8 givenname: Frank surname: de Pooter fullname: de Pooter, Frank – sequence: 9 givenname: Walter surname: de Wit fullname: de Wit, Walter – sequence: 10 givenname: Gilbert E surname: Cramer fullname: Cramer, Gilbert E – sequence: 11 givenname: Roland R J orcidid: 0000-0002-8207-8906 surname: van Kimmenade fullname: van Kimmenade, Roland R J – sequence: 12 givenname: Eva surname: Ouwendijk fullname: Ouwendijk, Eva – sequence: 13 givenname: Martijn H orcidid: 0000-0003-4640-1830 surname: Rutten fullname: Rutten, Martijn H – sequence: 14 givenname: Erwin surname: Zegers fullname: Zegers, Erwin – sequence: 15 givenname: Robert-Jan M orcidid: 0000-0003-2943-5932 surname: van Geuns fullname: van Geuns, Robert-Jan M – sequence: 16 givenname: Marc E R surname: Gomes fullname: Gomes, Marc E R – sequence: 17 givenname: Peter orcidid: 0000-0002-9284-7967 surname: Damman fullname: Damman, Peter – sequence: 18 givenname: Niels orcidid: 0000-0001-6136-8640 surname: van Royen fullname: van Royen, Niels email: Niels.vanroyen@radboudumc.nl |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38236708$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEYhQep2Fp77Z0EvBFhuvmYr3gjS_ELCoqu1yGbebObJZNsk5nC_hF_r--ya7VFlFwkzDznvDnhPC1OQgxQFM8ZvWRUihmsNzfGxNmN0UBp9ag447TuStZW_OR4rjmvT4uLnDeUUtaIlrHmSXEqOi6alnZnxY8vCcp1zFs3ak_S5KGM00iiJTis_LYoM6wGCCMBD7d6dDEQbaYRiIkpBp12JO9Cn-IAZLkjmmQXVh7ImOI2BhfeEOsCGuPFyx3oRNDcIJz3E8Y1kPnXxaerOUk69HFwGXqUOu2fFY-t9hkujvt58f39u8XVx_L68wfkr0tT82osl73hXDZcN5Z20C0p5z2TVddABU3LKtbYVlQ1tdzWVSc6wVkvuLais4JL3M-Ltwff7bQcoDeYNGmvtskNmE1F7dT9P8Gt1SreKsYEbZls0eHV0SHFmwnyqDCGAe91gDhlxSWXtG6l5Ii-fIBu4pTwebISVErBW17J39RKe1Au2IiDzd5UzbuacaRohdTlXyhcPQzO4HNbh9_vCV78mfQu4q8qIDA7ACbFnBPYO4RRte-bOvZNHfuGivqBwmCL9h3Buzj_D93rgy5O2_8O-QmK1-vd |
| CitedBy_id | crossref_primary_10_1093_ehjqcco_qcae023 crossref_primary_10_18203_2394_6040_ijcmph20250074 crossref_primary_10_1093_jalm_jfae161 crossref_primary_10_3390_jcm13247570 |
| Cites_doi | 10.1016/j.jval.2016.01.003 10.7754/Clin.Lab.2016.160814 10.1093/ehjacc/zuab109 10.1161/CIR.0b013e3181ec61df 10.1016/j.jacc.2022.03.380 10.1093/eurheartj/ehaa624 10.1097/HPC.0b013e3182953359 10.1093/eurheartj/ehad116 10.1371/journal.pone.0187477 10.1097/HPC.0000000000000070 10.7326/M16-2776 10.1016/j.jacc.2021.07.053 10.1056/NEJM200004203421607 10.1136/emermed-2020-210212 10.1136/bmj.f3197 10.1136/bmjopen-2019-034403 10.1001/jamainternmed.2022.6409 10.1136/emermed-2018-207540 10.1186/s12913-022-08697-6 10.1016/j.annemergmed.2018.12.010 10.1097/MCA.0000000000000474 10.7326/M16-1600 10.1093/eurheartj/ehad056 10.1097/HPC.0000000000000090 10.1007/s11739-016-1461-3 10.1016/j.annemergmed.2006.01.032 10.1007/BF03086144 10.1016/j.annemergmed.2012.10.026 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024 The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. COPYRIGHT 2024 Oxford University Press |
| Copyright_xml | – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024 – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. – notice: COPYRIGHT 2024 Oxford University Press |
| DBID | TOX AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1093/ehjqcco/qcae004 |
| DatabaseName | Oxford Journals Open Access Collection CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection (NC LIVE) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2058-1742 |
| EndPage | 420 |
| ExternalDocumentID | PMC11307197 A851227204 38236708 10_1093_ehjqcco_qcae004 10.1093/ehjqcco/qcae004 |
| Genre | Randomized Controlled Trial Multicenter Study Journal Article |
| GeographicLocations | Netherlands |
| GeographicLocations_xml | – name: Netherlands |
| GrantInformation_xml | – fundername: ZonMw grantid: 852001942 – fundername: ; grantid: 852001942 |
| GroupedDBID | 0R~ 1TH 48X 53G 5WD 7X7 88E 8FI 8FJ AABZA AACZT AAJQQ AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP ABDFA ABEJV ABGNP ABJNI ABNHQ ABPQP ABPTD ABQNK ABUWG ABVGC ABWST ABXVV ACGFS ADBBV ADGZP ADHKW ADIPN ADNBA ADQBN ADRTK ADVEK AEMDU AEMQT AENZO AETBJ AEWNT AFFZL AFKRA AFOFC AFXAL AGINJ AGORE AGQXC AGUTN AHGBF AHMBA AHMMS AJBYB AJEEA AJNCP ALIPV ALMA_UNASSIGNED_HOLDINGS ALXQX APIBT ATGXG AVWKF BAYMD BCRHZ BENPR BEYMZ BHONS BPHCQ BTRTY BVXVI C45 CCPQU CDBKE DAKXR EBS EJD ENERS FECEO FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC H13 HMCUK IAO IHR ITC KBUDW KOP KSI KSN M1P MHKGH NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OJZSN OPAEJ OVD OWPYF PAFKI PEELM PHGZM PHGZT PQQKQ PROAC PSQYO ROX RUSNO TEORI TJX TOX UKHRP YAYTL YKOAZ YXANX AAYXX CITATION CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS PUEGO 7X8 5PM |
| ID | FETCH-LOGICAL-c524t-bdc22962a6f08e8b022d19486e4e671416f73450f2f54838321d32af38f329af3 |
| IEDL.DBID | 7X7 |
| ISSN | 2058-5225 2058-1742 |
| IngestDate | Thu Aug 21 18:31:52 EDT 2025 Sun Sep 28 07:31:12 EDT 2025 Fri Sep 19 20:52:16 EDT 2025 Wed Aug 13 23:53:07 EDT 2025 Tue Aug 19 03:41:21 EDT 2025 Thu Apr 03 07:03:49 EDT 2025 Tue Jul 01 01:42:36 EDT 2025 Thu Apr 24 23:07:34 EDT 2025 Mon Jun 30 08:34:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Healthcare economics Point-of-care troponin Acute coronary syndrome Ambulance Cost-effectiveness |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c524t-bdc22962a6f08e8b022d19486e4e671416f73450f2f54838321d32af38f329af3 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Both authors contributed equally. |
| ORCID | 0000-0002-8207-8906 0000-0002-9284-7967 0000-0001-6136-8640 0000-0003-2943-5932 0000-0003-2706-9326 0000-0003-4912-295X 0000-0002-4773-6176 0000-0003-4640-1830 0000-0001-6170-8318 |
| OpenAccessLink | https://dx.doi.org/10.1093/ehjqcco/qcae004 |
| PMID | 38236708 |
| PQID | 3099327249 |
| PQPubID | 2046365 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11307197 proquest_miscellaneous_2929057992 proquest_journals_3099327249 gale_infotracmisc_A851227204 gale_infotracacademiconefile_A851227204 pubmed_primary_38236708 crossref_primary_10_1093_ehjqcco_qcae004 crossref_citationtrail_10_1093_ehjqcco_qcae004 oup_primary_10_1093_ehjqcco_qcae004 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-01 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | European heart journal. Quality of care & clinical outcomes |
| PublicationTitleAlternate | Eur Heart J Qual Care Clin Outcomes |
| PublicationYear | 2024 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | Laureano-Phillips (2024080811514895500_bib12) 2019; 74 Camaro (2024080811514895500_bib15) 2023; 44 Gigante (2024080811514895500_bib27) 2023; 44 Santi (2024080811514895500_bib24) 2017; 12 Lee (2024080811514895500_bib4) 2000; 342 Sun (2024080811514895500_bib5) 2013; 61 Six (2024080811514895500_bib11) 2008; 16 Melki (2024080811514895500_bib21) 2013; 12 Jungbauer (2024080811514895500_bib16) 2017; 63 Writing Committee (2024080811514895500_bib3) 2021; 78 Kanters (2024080811514895500_bib17) 2017; 12 Smits (2024080811514895500_bib28) 2017; 166 Johannessen (2024080811514895500_bib10) 2022; 22 Chase (2024080811514895500_bib7) 2006; 48 Amsterdam (2024080811514895500_bib9) 2010; 122 Sagel (2024080811514895500_bib8) 2021; 38 Jain (2024080811514895500_bib20) 2016; 15 Versteegh (2024080811514895500_bib19) 2016; 19 Niven (2024080811514895500_bib26) 2018; 35 Dawson (2024080811514895500_bib1) 2022; 79 Poldervaart (2024080811514895500_bib6) 2017; 166 Tolsma (2024080811514895500_bib13) 2022; 11 Dawson (2024080811514895500_bib25) 2023; 183 Wang (2024080811514895500_bib22) 2016; 15 Collet (2024080811514895500_bib2) 2020; 41 Aarts (2024080811514895500_bib14) 2020; 10 Patnaik (2024080811514895500_bib23) 2017; 28 Busse (2024080811514895500_bib18) 2013; 346 38692850 - Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):384-385. doi: 10.1093/ehjqcco/qcae023. |
| References_xml | – volume: 19 start-page: 343 year: 2016 ident: 2024080811514895500_bib19 article-title: Dutch tariff for the five-level version of EQ-5D publication-title: Value Health doi: 10.1016/j.jval.2016.01.003 – volume: 63 start-page: 633 year: 2017 ident: 2024080811514895500_bib16 article-title: Analytical and clinical validation of a point-of-care cardiac troponin t test with an improved detection limit publication-title: Clin Lab doi: 10.7754/Clin.Lab.2016.160814 – volume: 11 start-page: 160 year: 2022 ident: 2024080811514895500_bib13 article-title: Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study publication-title: Eur Heart J Acute Cardiovasc Care doi: 10.1093/ehjacc/zuab109 – volume: 122 start-page: 1756 year: 2010 ident: 2024080811514895500_bib9 article-title: Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0b013e3181ec61df – volume: 79 start-page: 2333 year: 2022 ident: 2024080811514895500_bib1 article-title: Care models for acute chest pain that improve outcomes and efficiency: JACC state-of-the-art review publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2022.03.380 – volume: 41 start-page: 3495 year: 2020 ident: 2024080811514895500_bib2 article-title: 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa624 – volume: 12 start-page: 127 year: 2013 ident: 2024080811514895500_bib21 article-title: HEART score: a simple and useful tool that may lower the proportion of chest pain patients who are admitted publication-title: Crit Pathw Cardiol doi: 10.1097/HPC.0b013e3182953359 – volume: 44 start-page: 1715 year: 2023 ident: 2024080811514895500_bib27 article-title: To be or not to be admitted to the emergency department for chest pain? A costly dilemma publication-title: Eur Heart J doi: 10.1093/eurheartj/ehad116 – volume: 12 start-page: e0187477 year: 2017 ident: 2024080811514895500_bib17 article-title: Update of the Dutch manual for costing studies in health care publication-title: PLoS One doi: 10.1371/journal.pone.0187477 – volume: 15 start-page: 40 year: 2016 ident: 2024080811514895500_bib20 article-title: Short- and long-term prognostic utility of the HEART score in patients evaluated in the emergency department for possible acute coronary syndrome publication-title: Crit Pathw Cardiol doi: 10.1097/HPC.0000000000000070 – volume: 166 start-page: 737 year: 2017 ident: 2024080811514895500_bib28 article-title: The development and performance of after-hours primary care in the netherlands: a narrative review publication-title: Ann Intern Med doi: 10.7326/M16-2776 – volume: 78 start-page: e187 year: 2021 ident: 2024080811514895500_bib3 article-title: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2021.07.053 – volume: 342 start-page: 1187 year: 2000 ident: 2024080811514895500_bib4 article-title: Evaluation of the patient with acute chest pain publication-title: N Engl J Med doi: 10.1056/NEJM200004203421607 – volume: 38 start-page: 814 year: 2021 ident: 2024080811514895500_bib8 article-title: Prehospital risk stratification in patients with chest pain publication-title: Emerg Med J doi: 10.1136/emermed-2020-210212 – volume: 346 start-page: f3197 year: 2013 ident: 2024080811514895500_bib18 article-title: Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? publication-title: BMJ doi: 10.1136/bmj.f3197 – volume: 10 start-page: e034403 year: 2020 ident: 2024080811514895500_bib14 article-title: Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial publication-title: BMJ Open doi: 10.1136/bmjopen-2019-034403 – volume: 183 start-page: 203 year: 2023 ident: 2024080811514895500_bib25 article-title: Chest pain management using prehospital point-of-care troponin and paramedic risk assessment publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2022.6409 – volume: 35 start-page: 732 year: 2018 ident: 2024080811514895500_bib26 article-title: Do all HEART scores beat the same: evaluating the interoperator reliability of the HEART Score publication-title: Emerg Med J doi: 10.1136/emermed-2018-207540 – volume: 22 start-page: 1274 year: 2022 ident: 2024080811514895500_bib10 article-title: Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting publication-title: BMC Health Serv Res doi: 10.1186/s12913-022-08697-6 – volume: 74 start-page: 187 year: 2019 ident: 2024080811514895500_bib12 article-title: HEART score risk stratification of low-risk chest pain patients in the emergency department: a systematic review and meta-analysis publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2018.12.010 – volume: 28 start-page: 336 year: 2017 ident: 2024080811514895500_bib23 article-title: Clinical utility of the HEART score in patients admitted with chest pain to an inner-city hospital in the USA publication-title: Coron Artery Dis doi: 10.1097/MCA.0000000000000474 – volume: 166 start-page: 689 year: 2017 ident: 2024080811514895500_bib6 article-title: Effect of using the HEART score in patients with chest pain in the emergency department: a stepped-wedge, cluster randomized trial publication-title: Ann Intern Med doi: 10.7326/M16-1600 – volume: 44 start-page: 1705 year: 2023 ident: 2024080811514895500_bib15 article-title: Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehad056 – volume: 15 start-page: 145 year: 2016 ident: 2024080811514895500_bib22 article-title: Chest pain risk scores can reduce emergent cardiac imaging test needs with low major adverse cardiac events occurrence in an emergency department observation unit publication-title: Crit Pathw Cardiol doi: 10.1097/HPC.0000000000000090 – volume: 12 start-page: 357 year: 2017 ident: 2024080811514895500_bib24 article-title: The HEART score with high-sensitive troponin T at presentation: ruling out patients with chest pain in the emergency room publication-title: Intern Emerg Med doi: 10.1007/s11739-016-1461-3 – volume: 48 start-page: 252 year: 2006 ident: 2024080811514895500_bib7 article-title: Prospective validation of the thrombolysis in myocardial infarction risk score in the emergency department chest pain population publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2006.01.032 – volume: 16 start-page: 191 year: 2008 ident: 2024080811514895500_bib11 article-title: Chest pain in the emergency room: value of the HEART score publication-title: Neth Heart J doi: 10.1007/BF03086144 – volume: 61 start-page: 605 year: 2013 ident: 2024080811514895500_bib5 article-title: Effect of emergency department crowding on outcomes of admitted patients publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2012.10.026 – reference: 38692850 - Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):384-385. doi: 10.1093/ehjqcco/qcae023. |
| SSID | ssj0001637116 |
| Score | 2.3073556 |
| Snippet | Background and aims
The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of... The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and... Background and aims The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of... Graphical Abstract Overview of the study design and outcomes. |
| SourceID | pubmedcentral proquest gale pubmed crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 411 |
| SubjectTerms | Acute Coronary Syndrome - blood Acute Coronary Syndrome - complications Acute Coronary Syndrome - epidemiology Acute coronary syndromes Aged Biomarkers - blood Coronary heart disease Cost analysis Cost-Benefit Analysis Electrocardiography Emergency Medical Services Female Follow-Up Studies Health care expenditures Humans Male Medical care Middle Aged Non-ST Elevated Myocardial Infarction - blood Non-ST Elevated Myocardial Infarction - epidemiology Original Quality management Quality of Life Time Factors Troponin - blood |
| Title | Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38236708 https://www.proquest.com/docview/3099327249 https://www.proquest.com/docview/2929057992 https://pubmed.ncbi.nlm.nih.gov/PMC11307197 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fb9MwELZgkxAviN8EymQEEryYJXZiJ7ygMm0aSBsTdFLfIsex6VCVbE360H-Ev5e7xOkWJOCpquzaae7s--7Ovo-QNzZVhUq0YdJkIcPUGkulTVhWlCUY3FI6jY7iyak8Po-_zJO5D7g1_ljlsCd2G3VZG4yR7wuAMoIr8BY-Xl4xZI3C7Kqn0LhNdiNAIkjdoObqOsYihYo69lMeJin4XDwZqvtkYt8ufl4ZU2PhABt6orbBMPnteXTn7Qb0_PME5Q2TdHSf3PNYkk574T8gt2z1kNw58dnyR-TX2cqyhScGoav10rJ63dLaUfD52fcZa-wPDA5SvGPeSYhqs24tNVjWQK82dKhnQIsN1RTDCktLWyRWqC6qD9QhpRatK8s2sGAoDA7v0jY4A-BKClj588GUgjUsa1AnW9KOI-QxOT86nB0cM8_DwEzC45YVpeE8k1xLF6Y2LcDsl1EWg0xjK1UEkM4pESeh4w78H4HcR6Xg2onUCZ7B5xOyA__LPiPUaCnLuBCuSMEsaptGklt0qgpAJjoWAXk_CCE3vkg5cmUs8z5ZLnIvtdxLLSDvtj-47Otz_L3rW5RqjisXxjTaX0CAJ8MaWPkUwCfHtDT0nIx6wisyo-bXoBf_n24y6E3u94Umv9bigLzaNuP4eNatsvW6yTkgVrwinPGAPO3VbDsXZm2lCtOApCMF3HbAauHjlupi0VUNjwCtqChTz__9XC_IXQ64rT_jOCE77WptXwLuaou9bnHtkd1Ph6dn3-Db7Ov8N9fTMgM |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJ8FeEP8pFDACBC9mqZ04CdKEBmzq2FpN0El7C47trENVsrWJUL8IH4fPxl3idCsS8LSnPti13d7Z9zuf736EvLRRmIaB0kzq2GMYWmORtAGLU2PA4BqZKXQUhyM5OPI_HwfHa-RXmwuDzyrbM7E-qE2h8Y58UwCUETwEb-H92TlD1iiMrrYUGspRK5itusSYS-zYt4sf4MLNt_Y-gbxfcb67M_44YI5lgOmA-yVLjeY8llzJzItslIJRM-DZw4p9K8M-AJYsFH7gZTwDdC-Q2ccIrjIRZYLH8AnjXiPrPl6gdMj6h53R4ZeLWx4pwn7Nv8q9IAKvjwdtfaFYbNrJ93NYOJYusJ6jimtNozMQK1l3l8Dvn284LxnF3VvkpkOzdLtRv9tkzeZ3yPWhi9ffJT8PZ5ZNHDUJnVVTy4qqpEVG8yJnX8dsbk_wepJilnutI1TpqrRUY2EFNVvQtqICTRdUUbzYmFpaIrVDfpq_oxmSetEit2wBsqAwOEjTznEGQLYU0DrIgII9NgUotDW0Zim5R46uREb3SQd-l31IqFZSGj8VWRqBYVY26ktu0a1LARspX3TJ21YIiXZl0pGtY5o04XqROKklTmpd8mb5hbOmQsjfu75GqSZ4dsCYWrkUCFgZVuFKtgH-cgyMQ8_eSk_4i_RK8wvQi_9P12v1JnEn0zy52Edd8nzZjOPja7vcFtU84YCZMUk55l3yoFGz5VwYN5ahF3VJtKKAyw5Yr3y1JT-d1HXL-4CXwn4cPvr3up6RG4Px8CA52BvtPyYbHFBk8-KyRzrlrLJPAAWW6VO31Sj5dtW7-zcBrHC7 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pre-hospital+rule-out+of+non-ST-segment+elevation+acute+coronary+syndrome+by+a+single+troponin%3A+final+one+-year+outcomes+of+the+ARTICA+randomised+trial&rft.jtitle=European+heart+journal.+Quality+of+care+%26+clinical+outcomes&rft.au=Aarts%2C+Goaris+W.A&rft.au=Camaro%2C+Cyril&rft.au=Adang%2C+Eddy+M.M&rft.au=Rodwell%2C+Laura&rft.date=2024-08-01&rft.pub=Oxford+University+Press&rft.issn=2058-5225&rft.volume=10&rft.issue=5&rft.spage=411&rft_id=info:doi/10.1093%2Fehjqcco%2Fqcae004&rft.externalDocID=A851227204 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2058-5225&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2058-5225&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2058-5225&client=summon |